How much does vaccination reduce the rate of HBV infection in Iranian population? a Bayesian adjustment analysis.
Bayesian adjustment
Hepatitis B virus
Misclassification
Underreporting
Vaccination
Journal
Gastroenterology and hepatology from bed to bench
ISSN: 2008-2258
Titre abrégé: Gastroenterol Hepatol Bed Bench
Pays: Iran
ID NLM: 101525875
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
27
2
2020
pubmed:
27
2
2020
medline:
27
2
2020
Statut:
ppublish
Résumé
The aim of this research was to estimate the changing rate of odds ratio (OR) by varying degrees of hepatitis B virus (HBV) underreporting. Data registering is usually associated with extensive errors such as misclassification, under-reporting, missing data due to lack of co-operation, error prone factors, and in medical studies, inadequate diagnosis of physicians or low accuracy of laboratory tests. In the present study, which discuss the actual impact of vaccination on HBV prevention, exposure and response were prone to various errors. Furthermore, some people in the community are possibly infected to the virus while were not reported in the count of patients with HBV infection. This was a case control study. Cases included patients with HBV referring to the gastroenterology and liver disease research center. The control group included patients without HBV who underwent a fatty liver test at Taleghani hospital laboratory. Bayesian approach and Gibbs sampling algorithm were used to estimate OR. According to results, misclassification rate was mild in raw data, but with an increase in degree of underreporting for 50 and 500 of unreported cases, OR increased by about half and more than double, respectively, while sensitivity diminished strikingly. Our analysis asserted that knowing the degree of underreporting is essential to accurately calculate OR and sensitivity. In addition, despite varying OR in different samples, overall the results were similar according to the pattern of exposure and response association.
Sections du résumé
AIM
OBJECTIVE
The aim of this research was to estimate the changing rate of odds ratio (OR) by varying degrees of hepatitis B virus (HBV) underreporting.
BACKGROUND
BACKGROUND
Data registering is usually associated with extensive errors such as misclassification, under-reporting, missing data due to lack of co-operation, error prone factors, and in medical studies, inadequate diagnosis of physicians or low accuracy of laboratory tests. In the present study, which discuss the actual impact of vaccination on HBV prevention, exposure and response were prone to various errors. Furthermore, some people in the community are possibly infected to the virus while were not reported in the count of patients with HBV infection.
METHODS
METHODS
This was a case control study. Cases included patients with HBV referring to the gastroenterology and liver disease research center. The control group included patients without HBV who underwent a fatty liver test at Taleghani hospital laboratory. Bayesian approach and Gibbs sampling algorithm were used to estimate OR.
RESULTS
RESULTS
According to results, misclassification rate was mild in raw data, but with an increase in degree of underreporting for 50 and 500 of unreported cases, OR increased by about half and more than double, respectively, while sensitivity diminished strikingly.
CONCLUSION
CONCLUSIONS
Our analysis asserted that knowing the degree of underreporting is essential to accurately calculate OR and sensitivity. In addition, despite varying OR in different samples, overall the results were similar according to the pattern of exposure and response association.
Types de publication
Journal Article
Langues
eng
Pagination
S136-S144Informations de copyright
©2019 RIGLD.
Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.
Références
PLoS One. 2019 Jun 6;14(6):e0217455
pubmed: 31170165
Gastroenterol Hepatol Bed Bench. 2013 Summer;6(3):136-40
pubmed: 24834260
Ann Clin Microbiol Antimicrob. 2005 Sep 13;4:13
pubmed: 16159399
J Gastroenterol Hepatol. 2008 Apr;23(4):512-20
pubmed: 18397482
Gastroenterol Hepatol Bed Bench. 2011 Fall;4(4):171-4
pubmed: 24834179
MMWR Morb Mortal Wkly Rep. 2013 Feb 15;62(6):99-102
pubmed: 23407125
J Hepatol. 2009 Sep;51(3):423-5
pubmed: 19596479
Vaccine. 2012 Mar 9;30(12):2212-9
pubmed: 22273662
Gastroenterology. 2010 May;138(5):1747-54
pubmed: 20114048
Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S38-S43
pubmed: 29511470
Hepatology. 2009 May;49(5 Suppl):S13-21
pubmed: 19399811
World J Gastroenterol. 2016 Aug 28;22(32):7264-74
pubmed: 27621573
BMC Infect Dis. 2015 Mar 25;15:149
pubmed: 25884719
Cancer Epidemiol. 2013 Apr;37(2):121-6
pubmed: 23290580
J Res Med Sci. 2009 Jul;14(4):249-58
pubmed: 21772891
Hepat Mon. 2011 May;11(5):346-50
pubmed: 22087159
East Mediterr Health J. 2005 Jan-Mar;11(1-2):62-7
pubmed: 16532672
Am J Epidemiol. 2016 Jun 1;183(11):1063-70
pubmed: 27188939
Hepat Mon. 2016 Apr 26;16(4):e35577
pubmed: 27257428
East Mediterr Health J. 2006 Sep;12(5):528-37
pubmed: 17333790
East Mediterr Health J. 2000 Mar-May;6(2-3):372-7
pubmed: 11556026
Gastroenterol Hepatol Bed Bench. 2018 Spring;11(2):91-100
pubmed: 29910849